Translational continuity: understanding why drug candidates fail in early development
Published 31 July 2026
Drug discovery and development remain inherently risky processes, with more than 90% of therapeutic candidates entering clinical testing ultimately failing to achieve regulatory approval.1 A significant proportion of ...Continue reading
